Wael Abuzeid1,2, Robert M Iwanochko1,2,3, Xuesong Wang4, S Joseph Kim2,5, Mansoor Husain1,2,3,6, Douglas S Lee7,8,9,10. 1. Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada. 2. University of Toronto, Toronto, ON, Canada. 3. Robert J. Burns Nuclear Cardiology Laboratory and Joint Department of Medical Imaging, University Health Network, Toronto, ON, Canada. 4. Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. 5. Division of Nephrology, University Health Network, Toronto, ON, Canada. 6. Ted Rogers Centre for Heart Research, Toronto, ON, Canada. 7. Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada. dlee@ices.on.ca. 8. University of Toronto, Toronto, ON, Canada. dlee@ices.on.ca. 9. Robert J. Burns Nuclear Cardiology Laboratory and Joint Department of Medical Imaging, University Health Network, Toronto, ON, Canada. dlee@ices.on.ca. 10. Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. dlee@ices.on.ca.
Abstract
BACKGROUND: While renal transplantation is increasingly performed for end-stage renal disease, there is a paucity of data on cardiac screening and prognostication post-transplant. We determined the prognostic value of SPECT-MPI in a cohort who underwent renal transplantation. METHODS: Among 4933 renal transplant recipients identified from the Canadian Organ Replacement Register, we examined outcomes of patients who underwent SPECT-MPI in Ontario, Canada. We determined morbidity and mortality using hospitalization and vital statistics registries, according to SPECT-MPI findings. RESULTS: We studied 282 renal transplant recipients (median age 46 years [25th, 75th percentile 37, 58]) with detailed SPECT-MPI results available, followed for a median of 5.7 (3.3, 7.7) years. Among those undergoing SPECT-MPI (66% pharmacologic stress), 41% had an abnormal summed stress score (SSS > 0) and 31% demonstrated abnormal summed difference score (SDS > 0). Rates of cardiovascular death were 0.4 per 100 person-years among those with normal stress perfusion (SSS = 0) and 0.4 per 100 person-years with SDS = 0. After adjusting for age, sex, prior myocardial infarction (MI), and cardiac risk factors, an SSS ≥ 4 conferred increased risk of cardiovascular death or cardiovascular hospitalization with adjusted hazard ratios of 2.52 (95% CI 1.41, 4.52, P = .002) for SSS 4-6 and 2.61 (95% CI 1.52, 4.49, P < .001) for SSS ≥ 7. SDS was a significant predictor of cardiovascular death or hospitalization, with adjusted hazard ratios of 2.96 (95% CI 1.72, 5.09, P < .001) for SDS 4-6 and 3.26 (95% CI 1.64, 6.50, P < .001) for SDS ≥ 7. CONCLUSION: Among renal transplant recipients, SPECT-MPI predicted risk of cardiovascular death and cardiovascular hospitalization events.
BACKGROUND: While renal transplantation is increasingly performed for end-stage renal disease, there is a paucity of data on cardiac screening and prognostication post-transplant. We determined the prognostic value of SPECT-MPI in a cohort who underwent renal transplantation. METHODS: Among 4933 renal transplant recipients identified from the Canadian Organ Replacement Register, we examined outcomes of patients who underwent SPECT-MPI in Ontario, Canada. We determined morbidity and mortality using hospitalization and vital statistics registries, according to SPECT-MPI findings. RESULTS: We studied 282 renal transplant recipients (median age 46 years [25th, 75th percentile 37, 58]) with detailed SPECT-MPI results available, followed for a median of 5.7 (3.3, 7.7) years. Among those undergoing SPECT-MPI (66% pharmacologic stress), 41% had an abnormal summed stress score (SSS > 0) and 31% demonstrated abnormal summed difference score (SDS > 0). Rates of cardiovascular death were 0.4 per 100 person-years among those with normal stress perfusion (SSS = 0) and 0.4 per 100 person-years with SDS = 0. After adjusting for age, sex, prior myocardial infarction (MI), and cardiac risk factors, an SSS ≥ 4 conferred increased risk of cardiovascular death or cardiovascular hospitalization with adjusted hazard ratios of 2.52 (95% CI 1.41, 4.52, P = .002) for SSS 4-6 and 2.61 (95% CI 1.52, 4.49, P < .001) for SSS ≥ 7. SDS was a significant predictor of cardiovascular death or hospitalization, with adjusted hazard ratios of 2.96 (95% CI 1.72, 5.09, P < .001) for SDS 4-6 and 3.26 (95% CI 1.64, 6.50, P < .001) for SDS ≥ 7. CONCLUSION: Among renal transplant recipients, SPECT-MPI predicted risk of cardiovascular death and cardiovascular hospitalization events.
Authors: Claudio Rigatto; Patrick Parfrey; Robert Foley; Carol Negrijn; Carrie Tribula; John Jeffery Journal: J Am Soc Nephrol Date: 2002-04 Impact factor: 10.121
Authors: Simon Winther; My Svensson; Hanne Skou Jørgensen; Kirsten Bouchelouche; Lars Christian Gormsen; Birgitte Bang Pedersen; Niels Ramsing Holm; Hans Erik Bøtker; Per Ivarsen; Morten Bøttcher Journal: JACC Cardiovasc Imaging Date: 2015-04-10
Authors: Sang Joseph Kim; Stanley Sa Fenton; Joanne Kappel; Louise M Moist; Scott W Klarenbach; Susan M Samuel; Lianne G Singer; Daniel H Kim; Kimberly Young; Greg Webster; Juliana Wu; Frank Ivis; Eric de Sa; John S Gill Journal: Can J Kidney Health Dis Date: 2014-12-09
Authors: Maneesh Sud; Xuesong Wang; Peter C Austin; Lorraine L Lipscombe; Gary E Newton; Jack V Tu; Ramachandran S Vasan; Douglas S Lee Journal: Eur Heart J Date: 2015-01-08 Impact factor: 29.983